Nystatin Cream/Powder
Brand names: Nystan, Timodine (with hydrocortisone)
Topical nystatin cream and powder are polyene antifungals used to treat cutaneous and mucocutaneous Candida infection, including intertriginous and moist skin candidiasis that can complicate burns and donor sites.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Nystatin binds ergosterol in the fungal cell membrane, forming pores that disrupt membrane integrity and kill susceptible Candida species; it has no useful antibacterial activity.
Prescribing in practice
- It is effective only against Candida and other yeasts, not bacteria or dermatophytes, so confirm a fungal cause before relying on it and do not use it as broad antimicrobial cover.
- The powder is useful for moist skin folds and macerated areas while the cream suits drier intertriginous candidiasis; it is for topical use, not for systemic or deep infection.
- Negligible absorption through intact skin gives a wide safety margin, but it does not treat candidaemia or invasive fungal infection, which require systemic agents.
Monitoring
Monitor the treated skin for resolution of candidal rash and for any local irritation or sensitisation.
Counselling the patient
- This treats a yeast (thrush-type) skin infection, not bacteria.
- Keep affected skin folds clean and dry and apply as directed.
- Tell the team if the rash spreads or does not improve.
Evidence & guidelines
Topical nystatin for cutaneous candidiasis is established standard practice supported by dermatology and prescribing references.
Reference: BBA Burns Infection Management Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.